Reviva Pharmaceuticals Holdings, Inc.
RVPHOTCCIK 1742927HealthcareFiscal year ends Dec 31
Reports and events: 172 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1216:53 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027358 |
| 2026-08-1216:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027356 |
| 2026-05-1316:43 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016762 |
| 2026-05-1316:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016760 |
| 2026-05-1308:03 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001437749-26-016538 |
| 2026-04-1508:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012303 |
| 2026-03-3006:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-010140 |
| 2026-03-3020:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010126 |
| 2026-03-2416:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-012362 |
| 2026-03-1916:17 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-009063 |
| 2026-03-0508:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-006991 |
| 2026-01-2316:15 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001437749-26-001913 |
| 2025-12-2308:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038602 |
| 2025-12-2216:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-028783 |
| 2025-11-1316:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034846 |
| 2025-11-1316:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034827 |
| 2025-11-0416:16 ET | DEF 14A | Proxy statementPeriod 2025-12-18 | 0001437749-25-033023 |
| 2025-10-1716:31 ET | 8-K | 3.01 Delisting notice | 0001437749-25-031278 |
| 2025-09-2617:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-25-029951 |
| 2025-09-2416:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-25-029807 |
| 2025-09-2416:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-014806 |
| 2025-09-1917:27 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029531 |
| 2025-08-1416:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-026971 |
| 2025-08-1416:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026967 |
| 2025-07-0118:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-017411 |
| 2025-07-0116:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-25-021746 |
| 2025-06-2617:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-021361 |
| 2025-06-0616:06 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-019716 |
| 2025-06-0207:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019062 |
| 2025-05-3016:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-018972 |
| 2025-05-1516:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-017191 |
| 2025-05-1516:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-017185 |
| 2025-04-0319:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010791 |
| 2025-03-3116:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-010191 |
| 2025-02-1816:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-004224 |
| 2025-01-3121:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-004530 |
| 2024-12-2016:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-24-038128 |
| 2024-12-1819:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-037764 |
| 2024-12-1608:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037520 |
| 2024-12-1216:36 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-037373 |
| 2024-11-1417:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035391 |
| 2024-11-1417:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035375 |
| 2024-11-1208:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034338 |
| 2024-10-2816:17 ET | DEF 14A | Proxy statementPeriod 2024-12-10 | 0001437749-24-032297 |
| 2024-09-1717:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-029392 |
| 2024-08-2316:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-24-027668 |
| 2024-08-2316:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-24-027667 |
| 2024-08-2217:04 ET | 8-K/A | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027621 |
| 2024-08-2117:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027511 |
| 2024-08-1408:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026571 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.